COVID-19 Impact on Global Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Over-the-counter (OTC) Testing Kits
  • 1.4.3 Prescription-based Testing Kits
• 1.5 Market by Application
  • 1.5.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Bacterial Infections
  • 1.5.3 Fungal Infection
  • 1.5.4 Virus Infection
  • 1.5.5 Cardiovascular Infection
  • 1.5.6 Gastrointestinal Infection
  • 1.5.7 Sexually Transmitted Disease (STD) Infection
  • 1.5.8 Central Nervous System Infection
  • 1.5.9 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Infectious Disease Point of Care Diagnostics Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Infectious Disease Point of Care Diagnostics Industry
    • 1.6.1.1 Infectious Disease Point of Care Diagnostics Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Infectious Disease Point of Care Diagnostics Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Infectious Disease Point of Care Diagnostics Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Infectious Disease Point of Care Diagnostics Market Perspective (2015-2026)
• 2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Regions
  • 2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Infectious Disease Point of Care Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Infectious Disease Point of Care Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Market Size
  • 3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
  • 3.2.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2019
• 3.3 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
• 3.4 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
• 3.5 Date of Enter into Infectious Disease Point of Care Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2021-2026)

5 Infectious Disease Point of Care Diagnostics Breakdown Data by Application (2015-2026)

• 5.1 Global Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
• 5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
• 6.2 Infectious Disease Point of Care Diagnostics Key Players in North America (2019-2020)
• 6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
• 6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
• 7.2 Infectious Disease Point of Care Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
• 8.2 Infectious Disease Point of Care Diagnostics Key Players in China (2019-2020)
• 8.3 China Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
• 8.4 China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
• 9.2 Infectious Disease Point of Care Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
• 10.2 Infectious Disease Point of Care Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
• 11.2 Infectious Disease Point of Care Diagnostics Key Players in India (2019-2020)
• 11.3 India Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
• 11.4 India Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
• 12.2 Infectious Disease Point of Care Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview and Its Total Revenue
  • 13.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
  • 13.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 Siemens
  • 13.2.1 Siemens Company Details
  • 13.2.2 Siemens Business Overview and Its Total Revenue
  • 13.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
  • 13.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 13.2.5 Siemens Recent Development
• 13.3 GE Healthcare
  • 13.3.1 GE Healthcare Company Details
  • 13.3.2 GE Healthcare Business Overview and Its Total Revenue
  • 13.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
  • 13.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 13.3.5 GE Healthcare Recent Development
• 13.4 Accriva
  • 13.4.1 Accriva Company Details
  • 13.4.2 Accriva Business Overview and Its Total Revenue
  • 13.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
  • 13.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 13.4.5 Accriva Recent Development
• 13.5 Terumo
  • 13.5.1 Terumo Company Details
  • 13.5.2 Terumo Business Overview and Its Total Revenue
  • 13.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
  • 13.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 13.5.5 Terumo Recent Development
• 13.6 BioMerieux
  • 13.6.1 BioMerieux Company Details
  • 13.6.2 BioMerieux Business Overview and Its Total Revenue
  • 13.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
  • 13.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 13.6.5 BioMerieux Recent Development
• 13.7 Diasorin
  • 13.7.1 Diasorin Company Details
  • 13.7.2 Diasorin Business Overview and Its Total Revenue
  • 13.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
  • 13.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 13.7.5 Diasorin Recent Development
• 13.8 Roche
  • 13.8.1 Roche Company Details
  • 13.8.2 Roche Business Overview and Its Total Revenue
  • 13.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
  • 13.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 13.8.5 Roche Recent Development
• 13.9 Danaher Corporation
  • 13.9.1 Danaher Corporation Company Details
  • 13.9.2 Danaher Corporation Business Overview and Its Total Revenue
  • 13.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
  • 13.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 13.9.5 Danaher Corporation Recent Development
• 13.10 BD
  • 13.10.1 BD Company Details
  • 13.10.2 BD Business Overview and Its Total Revenue
  • 13.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
  • 13.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 13.10.5 BD Recent Development
• 13.11 Bio-Rad Laboratories
  • 10.11.1 Bio-Rad Laboratories Company Details
  • 10.11.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  • 10.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
  • 10.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.11.5 Bio-Rad Laboratories Recent Development
• 13.12 Cavidi
  • 10.12.1 Cavidi Company Details
  • 10.12.2 Cavidi Business Overview and Its Total Revenue
  • 10.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
  • 10.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.12.5 Cavidi Recent Development
• 13.13 Cepheid
  • 10.13.1 Cepheid Company Details
  • 10.13.2 Cepheid Business Overview and Its Total Revenue
  • 10.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
  • 10.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.13.5 Cepheid Recent Development
• 13.14 Diaxonhit
  • 10.14.1 Diaxonhit Company Details
  • 10.14.2 Diaxonhit Business Overview and Its Total Revenue
  • 10.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
  • 10.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.14.5 Diaxonhit Recent Development
• 13.15 Eiken Chemical
  • 10.15.1 Eiken Chemical Company Details
  • 10.15.2 Eiken Chemical Business Overview and Its Total Revenue
  • 10.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
  • 10.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.15.5 Eiken Chemical Recent Development
• 13.16 EMD Millipore
  • 10.16.1 EMD Millipore Company Details
  • 10.16.2 EMD Millipore Business Overview and Its Total Revenue
  • 10.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
  • 10.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.16.5 EMD Millipore Recent Development
• 13.17 Epitope Diagnostic
  • 10.17.1 Epitope Diagnostic Company Details
  • 10.17.2 Epitope Diagnostic Business Overview and Its Total Revenue
  • 10.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
  • 10.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.17.5 Epitope Diagnostic Recent Development
• 13.18 Euroimmun
  • 10.18.1 Euroimmun Company Details
  • 10.18.2 Euroimmun Business Overview and Its Total Revenue
  • 10.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
  • 10.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.18.5 Euroimmun Recent Development
• 13.19 Gold Standard Diagnostics
  • 10.19.1 Gold Standard Diagnostics Company Details
  • 10.19.2 Gold Standard Diagnostics Business Overview and Its Total Revenue
  • 10.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
  • 10.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.19.5 Gold Standard Diagnostics Recent Development
• 13.20 Hologic
  • 10.20.1 Hologic Company Details
  • 10.20.2 Hologic Business Overview and Its Total Revenue
  • 10.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
  • 10.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.20.5 Hologic Recent Development
• 13.21 Immunetics
  • 10.21.1 Immunetics Company Details
  • 10.21.2 Immunetics Business Overview and Its Total Revenue
  • 10.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
  • 10.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.21.5 Immunetics Recent Development
• 13.22 InBios International
  • 10.22.1 InBios International Company Details
  • 10.22.2 InBios International Business Overview and Its Total Revenue
  • 10.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
  • 10.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
  • 10.22.5 InBios International Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer